Labcorp projects upbeat annual profit on strong diagnostic test demand

Labcorp expects 2026 earnings to exceed estimates as demand for diagnostic tests remains high. The company also beat quarterly profit targets earlier today.

洞察:
Labcorp Holdings Inc. announced on Tuesday, February 17, 2026, that it has revised its 2026 financial outlook, forecasting annual adjusted profit above Wall Street estimates. The company, which operates primarily in the US USUS, cited robust demand for diagnostic tests as the primary driver for the updated guidance. This revision places the company’s adjusted earnings per share (EPS) midpoint above the average expectations of analysts, reflecting ongoing revenue and market-share expansion in laboratory diagnostics.
The logo for Labcorp, Laboratory Corporation of America, a life sciences company is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., June 22, 2023. REUTERS/Brendan McDermid
The logo for Labcorp, Laboratory Corporation of America, a life sciences company is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., June 22, 2023. REUTERS/Brendan McDermid
IUX24

IUX24 提供深度財經、經濟與投資資訊,藉助 AI 發掘全球市場中最重要的信號。

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. 版權所有。

由 AI 驅動 • 精益求精

IUX24 是一個資訊與分析平台,提供新聞、市場數據、分析工具及 AI 驅動的功能,僅供資訊參考與教育用途。所提供的服務和資訊不構成投資建議、交易信號或經紀服務。投資涉及風險,用戶在作出投資決定前應審慎評估相關資訊。